Dangerous antidiabetic overtreatment of patients with Typ 2 diabetes having experienced severe hypoglycaemia
F Trachte, T Wohland, OM Patzer, P Kovacs, JD Holstein, A Holstein · Diabetologie und Stoffwechsel · 2016 · Heft 06
Bibliografische Angaben
Zusammenfassung
Aims: Severe hypoglycaemia (SH) may increase cardiovascular and all-cause mortality in patients with long-standing complicated diabetes. We investigated whether in patients with T2DM who had experienced SH individual morbidity and treatment targets had sufficiently been respected. Methods: Prospective population-based observational trial capturing all episodes of SH between 2007 and 2014 in the Lippe-Detmold area. SH was defined as a symptomatic event requiring treatment with intravenous glucose or glucagon administration and being confirmed by a blood glucose measurement of < 50 mg/dl. Results: 51.9% (n = 561)…